Olema Pharmaceuticals Inc
About
Olema Pharmaceuticals Inc (NASDAQ:OLMA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
Apr 17 2026
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Mar 17 2026
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Mar 16 2026
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Feb 19 2026
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Financials
Revenue
$0
Market Cap
$1.32 B
EPS
-1.87